Loading...

Novan, Inc.

NOVN•NASDAQ
Healthcare
Biotechnology
$0.09
$-0.03(-24.84%)

Novan, Inc. (NOVN) Stock Overview

Explore Novan, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.3/100

Key Financials

Market Cap2.6M
P/E Ratio-0.11
EPS (TTM)$-0.84
ROE-1.71%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.03

NOVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novan, Inc. (NOVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.11 and a market capitalization of 2.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;